Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18 - Voltin, C.-A.; Goergen, H.; Baues, C.; Fuchs, M.; Mettler, J.; Kreissl, S.; Oertl, J.; Klaeser, B.; Moccia, A.; Drzezga, A.; Engert, A.; Borchmann, P.; et al. (Annals of oncology, 2018)
Keywords: Adolescent; Adult; Aged; Biopsy - standards; Bone Marrow - diagnostic imaging; Bone Marrow - pathology; bone marrow biopsy; bone marrow involvement; Clinical Trials, Phase III as Topic; Datasets as Topic; Female; Fluorodeoxyglucose F18 - administration & dosage; Germany; Hodgkin Disease - diagnosis; Hodgkin Disease - pathology; Hodgkin lymphoma; Humans; Male; Middle Aged; Neoplasm Staging; PET; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Randomized Controlled Trials as Topic; Reference Standards; staging; Young Adult; Germany; bone marrow biopsy; staging; PET; Hodgkin lymphoma; bone marrow involvement